Digoxin-verapamil Interaction
Overview
Affiliations
To explore a possible interaction between digoxin and verapamil, a single-dose kinetic study of digoxin was performed and then repeated after 10 days of verapamil treatment in eight healthy subjects. Verapamil diminished the apparent central distribution volume of digoxin from 0.83 +/- 0.25 to 0.64 +2- 0.17 l/kg (P less than 0.05) and reduced total body clearance of digoxin from 3.28 +/- 0.58 to 2.15 +/- 0.66 ml/min/kg (P less than 0.001) by impairing both renal and extrarenal clearance. Biological digoxin half-life rose from 38.6 +/- 8.5 to 50.5 +/- 8.3 hr (P less than 0.005). Reduction of renal clearance of digoxin may be due to inhibition of tubular secretion. The underlying mechanisms of extrarenal interaction are not known, but impaired hepatic degradation of digoxin induced by verapamil should be considered.
Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters.
Lin K, Kong X, Tao X, Zhai X, Lv L, Dong D Molecules. 2023; 28(13).
PMID: 37446913 PMC: 10343503. DOI: 10.3390/molecules28135252.
Kidney Drug Transporters in Pharmacotherapy.
Lapczuk-Romanska J, Drozdzik M, Oswald S, Drozdzik M Int J Mol Sci. 2023; 24(3).
PMID: 36769175 PMC: 9917665. DOI: 10.3390/ijms24032856.
Taskar K, Yang X, Neuhoff S, Patel M, Yoshida K, Paine M Clin Pharmacol Ther. 2022; 112(3):573-592.
PMID: 35612761 PMC: 9436425. DOI: 10.1002/cpt.2670.
Renal Drug Transporters and Drug Interactions.
Ivanyuk A, Livio F, Biollaz J, Buclin T Clin Pharmacokinet. 2017; 56(8):825-892.
PMID: 28210973 DOI: 10.1007/s40262-017-0506-8.
Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein.
Ledwitch K, Roberts A AAPS J. 2016; 19(2):409-420.
PMID: 28028729 PMC: 6309310. DOI: 10.1208/s12248-016-0023-y.